Patent ID: 11945778
Assignee: ENVERIC BIOSCIENCES CANADA INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 18:
19. A method according to claim 12, wherein the disorder is a 5-HT1A receptor-mediated disorder, a 5-HT2A receptor-mediated disorder, a 5-HT1B receptor-mediated disorder, a 5-HT2B receptor-mediated disorder, a 5-HT3A receptor-mediated disorder, an ADRA1A receptor-mediated disorder, an ADRA2A receptor-mediated disorder, a CHRM1 receptor-mediated disorder, a CHRM2 receptor-mediated disorder, a CNR1 receptor-mediated disorder, a DRD1 receptor-mediated disorder, a DRD2S receptor-mediated disorder, an OPRD1 receptor-mediated disorder, a GABAA receptor-mediated disorder, or a NMDAR receptor-mediated disorder.